Medigus Ltd (Israel) Profile

ILS 1.00  11.63%

Medigus Ltd Summary

Medigus Ltd (MDGS) is traded on Tel Aviv Stock Exchange in Israel. It is located in No. 7A, Industrial Park and employs 27 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 18.22 M. Medigus Ltd has 191.79 M outstanding shares. MEDIGUS has accumulated about 6.33 M in cash with (4.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03.
Check Medigus Ltd Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 9.6HorizonTargetOdds Above 9.6
?%30 days 9.60 ?%
Based on normal probability distribution, the odds of Medigus Ltd to move above current price in 30 days from now is about 0.0% (This Medigus Ltd probability density function shows the probability of Medigus Ltd Stock to fall within a particular range of prices over 30 days) .

Key Fundamentals

Medigus Ltd Against Markets

Current Ratings

Medigus Ltd 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Medigus Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Medigus Ltd., a medical device company, develops, manufactures, and markets surgical endostaplers and direct vision systems for minimally invasive medical procedures or other commercial use in the United States, Europe, Asia, and internationally. Medigus Ltd. was founded in 1999 and is based in Omer, Israel. Medigus Ltd operates under Medical Devices classification in Israel and traded on Tel Aviv Stock Exchange. It employs 27 people. more
NameMedigus Ltd
CEO and DirectorChristopher RowlandView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business AddressNo. 7A, Industrial Park
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
Contact Number972 72 260 2200
CurrencyILS - Israeli Shekel

Diversify with Medigus Ltd

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Medigus Ltd to your portfolio


Medigus Ltd Corporate Directors
Efrat Venkert External Director
Anat Naschitz Director, MBA
Ori Hershkovitz External Director
Please see also Stocks Correlation. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.